Insulet Price to Book Ratio 2010-2025 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of May 23, 2025 is 17.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Insulet Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-23 | 321.36 | 16.99 | |
| 2025-03-31 | 262.61 | $18.91 | 13.89 |
| 2024-12-31 | 261.07 | $17.26 | 15.13 |
| 2024-09-30 | 232.75 | $15.94 | 14.60 |
| 2024-06-30 | 201.80 | $14.24 | 14.17 |
| 2024-03-31 | 171.40 | $11.29 | 15.18 |
| 2023-12-31 | 216.98 | $10.48 | 20.70 |
| 2023-09-30 | 159.49 | $8.70 | 18.33 |
| 2023-06-30 | 288.34 | $7.94 | 36.34 |
| 2023-03-31 | 318.96 | $7.21 | 44.21 |
| 2022-12-31 | 294.39 | $6.85 | 42.95 |
| 2022-09-30 | 229.40 | $6.16 | 37.21 |
| 2022-06-30 | 217.94 | $6.09 | 35.80 |
| 2022-03-31 | 266.39 | $6.44 | 41.34 |
| 2021-12-31 | 266.07 | $8.04 | 33.09 |
| 2021-09-30 | 284.23 | $7.22 | 39.34 |
| 2021-06-30 | 274.51 | $6.69 | 41.02 |
| 2021-03-31 | 260.92 | $8.84 | 29.52 |
| 2020-12-31 | 255.63 | $9.14 | 27.96 |
| 2020-09-30 | 236.59 | $9.03 | 26.19 |
| 2020-06-30 | 194.26 | $8.59 | 22.62 |
| 2020-03-31 | 165.68 | $0.94 | 177.08 |
| 2019-12-31 | 171.20 | $1.21 | 141.39 |
| 2019-09-30 | 164.93 | $2.44 | 67.68 |
| 2019-06-30 | 119.38 | $4.15 | 28.75 |
| 2019-03-31 | 95.09 | $3.75 | 25.36 |
| 2018-12-31 | 79.32 | $3.58 | 22.14 |
| 2018-09-30 | 105.95 | $3.35 | 31.62 |
| 2018-06-30 | 85.70 | $3.04 | 28.21 |
| 2018-03-31 | 86.68 | $2.90 | 29.84 |
| 2017-12-31 | 69.00 | $2.72 | 25.39 |
| 2017-09-30 | 55.08 | $1.28 | 43.14 |
| 2017-06-30 | 51.31 | $1.12 | 46.01 |
| 2017-03-31 | 43.09 | $1.10 | 39.25 |
| 2016-12-31 | 37.68 | $1.10 | 34.28 |
| 2016-09-30 | 40.94 | $1.13 | 36.11 |
| 2016-06-30 | 30.24 | $0.48 | 63.08 |
| 2016-03-31 | 33.16 | $0.46 | 71.74 |
| 2015-12-31 | 37.81 | $0.60 | 63.24 |
| 2015-09-30 | 25.91 | $0.97 | 26.75 |
| 2015-06-30 | 30.99 | $1.24 | 25.09 |
| 2015-03-31 | 33.35 | $1.42 | 23.42 |
| 2014-12-31 | 46.06 | $1.49 | 30.93 |
| 2014-09-30 | 36.85 | $1.43 | 25.70 |
| 2014-06-30 | 39.67 | $1.40 | 28.27 |
| 2014-03-31 | 47.42 | $2.22 | 21.39 |
| 2013-12-31 | 37.10 | $2.27 | 16.34 |
| 2013-09-30 | 36.24 | $2.23 | 16.27 |
| 2013-06-30 | 31.41 | $2.55 | 12.34 |
| 2013-03-31 | 25.86 | $2.43 | 10.64 |
| 2012-12-31 | 21.22 | $0.91 | 23.23 |
| 2012-09-30 | 21.58 | $1.05 | 20.58 |
| 2012-06-30 | 21.37 | $1.23 | 17.33 |
| 2012-03-31 | 19.14 | $1.47 | 13.01 |
| 2011-12-31 | 18.83 | $1.74 | 10.81 |
| 2011-09-30 | 15.26 | $1.76 | 8.67 |
| 2011-06-30 | 22.17 | $1.99 | 11.13 |
| 2011-03-31 | 20.62 | $1.30 | 15.81 |
| 2010-12-31 | 15.50 | $1.46 | 10.63 |
| 2010-09-30 | 14.14 | $0.83 | 16.95 |
| 2010-06-30 | 15.05 | $1.10 | 13.73 |
| 2010-03-31 | 15.09 | $1.08 | 13.99 |
| 2009-12-31 | 14.28 | $1.64 | 8.71 |
| 2009-09-30 | 11.23 | $0.01 | 1145.92 |
| 2009-06-30 | 7.70 | $-0.12 | -61.90 |
| 2009-03-31 | 4.10 | $0.56 | 7.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.616B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |